Eléments de l'association

	Alexander S. Pristupa	1
	Neoplasm Recurrence, Local (drug therapy)	9
	Alexander S. Pristupa *Sauf* Neoplasm Recurrence, Local (drug therapy)"	0
	Neoplasm Recurrence, Local (drug therapy) *Sauf* Alexander S. Pristupa"	8
	Alexander S. Pristupa Et Neoplasm Recurrence, Local (drug therapy)	1
	Alexander S. Pristupa Ou Neoplasm Recurrence, Local (drug therapy)	9
	*Corpus*	4588

List of bibliographic references

Number of relevant bibliographic references: 1.

Ident.	Authors (with country if any)	Title
000302	Andrew D. Zelenetz [États-Unis] ; Jacqueline C. Barrientos [États-Unis] ; Jennifer R. Brown [États-Unis] ; Bertrand Coiffier [France] ; Julio Delgado [Espagne] ; Mikl S Egyed [Hongrie] ; Paolo Ghia [Italie] ; Árpád Illés [Hongrie] ; Wojciech Jurczak [Pologne] ; Paula Marlton [Australie] ; Marco Montillo [Italie] ; Franck Morschhauser [France] ; Alexander S. Pristupa [Russie] ; Tadeusz Robak [Pologne] ; Jeff P. Sharman [États-Unis] ; David Simpson [Nouvelle-Zélande] ; Lukáš Smolej [République tchèque] ; Eugen Tausch [Allemagne] ; Adeboye H. Adewoye [États-Unis] ; Lyndah K. Dreiling [États-Unis] ; Yeonhee Kim [États-Unis] ; Stephan Stilgenbauer [Allemagne] ; Peter Hillmen [Royaume-Uni]	Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial.

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024